|
UK
Drugs in Lactation Advisory Service
A
joint service provided by the West Midlands and Trent Drug Information
Services
Anti-asthma
agents | Anti-coagulants | Anti-convulsants
| Anti-depressants
Anti-diarrhoeals | Anti-histamines
| Anti-hypertensives | Corticosteroids
Laxatives | Non-steroidal
Anti-inflammatories | Vitamins
Breastfeeding
mothers and medicines - general guidance
The
following principles should be followed when prescribing for breastfeeding
mothers :
- Avoid
unnecessary drug use and limit use of over-the-counter (OTC) products
- Breastfeeding
mothers should seek advice on the suitability of OTC products
- Assess
the benefit/risk ratio for both mother and infant
- Avoid
use of drugs known to cause serious toxicity in adults or children
- Drugs
licensed for use in infants do not generally pose a hazard
- Neonates
(and particularly premature infants) are at greater risk from exposure
to drugs via breast milk, because of immature excretory functions and
the consequent risk of drug accumulation
- Choose
a regimen and route of administration which presents the minimum amount
of drug to the infant
- It
is best to avoid long-acting preparations, especially those of drugs
likely to cause serious side effects (e.g. antipsychotic agents), as
it is difficult to time feeds to avoid significant amounts of drug in
breast milk
-
Multiple drug regimens may pose an increased risk especially when adverse
effects such as drowsiness are additive
- Infants
exposed to drugs via breast milk should be monitored for unusual signs
or symptoms
- Avoid
new drugs if a therapeutically equivalent alternative that has been
more widely used is available. A robust assessment of the balance of
benefit to risk requires data both on the drug's passage into breast
milk and its effects in infants: there is rarely enough information
available for new drugs to allow such an assessment to be made. If a
drug with limited data is deemed to be clinically necessary or for any
further information, contact the UK Drugs in Lactation Advisory Service
for further advice - click here for contact details

|